Current evidence and indications for left atrial appendage closure.

Area of Science:

• Cardiology
• Medical Devices
• Interventional Cardiology

Background:

• Atrial fibrillation (AF) is a prevalent arrhythmia, increasing stroke risk.
• Oral anticoagulation (OAC) is standard but contraindicated/intolerable for many AF patients.
• The left atrial appendage (LAA) is a primary source of thrombus in AF.

Purpose of the Study:

• To review indications for percutaneous LAA closure (LAAC).
• To evaluate evidence for current LAAC device therapies.
• To examine challenges in patient selection and post-procedural care for LAAC.

Main Methods:

• Systematic review of LAAC literature.
• Analysis of safety and efficacy data for LAAC devices.
• Examination of clinical guidelines and expert consensus.

Main Results:

• LAAC is an effective stroke risk reduction strategy for OAC-intolerant AF patients.
• Newer generation LAAC devices show improved safety and efficacy.
• Patient selection and antithrombotic strategies require further optimization.

Conclusions:

• Percutaneous LAAC is a viable alternative to OAC for stroke prevention in select AF patients.
• Ongoing research is refining LAAC indications and management protocols.
• Optimizing patient selection and post-procedural care will enhance LAAC outcomes.